Van Hauwermeiren Timothy

Insider CIK 1816206 · DNLI Director · ITOS Director · RYZB Director · LXEO Director

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
LXEO Lexeo Therapeutics, Inc.	A Award deriv	2026-06-25	2026-06-29	35,000	—	$0	35,000	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2026-06-03	2026-06-05	19,226	—	$0	19,226	SEC↗
DNLI Denali Therapeutics Inc.	A Award	2026-06-03	2026-06-05	6,408	—	$0	17,040	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2025-11-04	2025-11-06	31,897	—	$0	31,897	SEC↗
DNLI Denali Therapeutics Inc.	A Award	2025-11-04	2025-11-06	10,632	—	$0	10,632	SEC↗
LXEO Lexeo Therapeutics, Inc.	A Award deriv	2025-06-26	2025-06-30	22,916	—	$0	22,916	SEC↗
ITOS iTeos Therapeutics, Inc.	M Exercise deriv	2025-05-13	2025-05-14	22,346	—	$0	0	SEC↗
ITOS iTeos Therapeutics, Inc.	M Exercise	2025-05-13	2025-05-14	22,346	$4.30	$96.1K	22,346	SEC↗
LXEO Lexeo Therapeutics, Inc.	A Award deriv	2024-07-05	2024-07-08	36,000	—	$0	36,000	SEC↗
ITOS iTeos Therapeutics, Inc.	A Award deriv	2024-06-11	2024-06-13	24,200	—	$0	24,200	SEC↗
RYZB RayzeBio, Inc.	D To issuer deriv	2024-02-26	2024-02-27	48,628	—	$0	0	SEC↗
RYZB RayzeBio, Inc.	A Award deriv	2023-11-01	2023-11-01	48,628	—	$0	48,628	SEC↗
ITOS iTeos Therapeutics, Inc.	A Award deriv	2023-06-13	2023-06-15	22,383	—	$0	22,383	SEC↗
ITOS iTeos Therapeutics, Inc.	A Award deriv	2022-06-09	2022-06-10	17,538	—	$0	17,538	SEC↗
ITOS iTeos Therapeutics, Inc.	A Award deriv	2021-06-17	2021-06-21	16,608	—	$0	0	SEC↗
ITOS iTeos Therapeutics, Inc.	A Award deriv	2020-07-23	2020-10-21	16,608	—	$0	0	SEC↗
ITOS iTeos Therapeutics, Inc.	A Award deriv	2020-07-23	2020-07-24	16,608	—	$0	0	SEC↗